336 related articles for article (PubMed ID: 25435435)
1. Autophagy and senescence in fibrosing cholangiopathies.
Nakanuma Y; Sasaki M; Harada K
J Hepatol; 2015 Apr; 62(4):934-45. PubMed ID: 25435435
[TBL] [Abstract][Full Text] [Related]
2. Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target.
Trussoni CE; O'Hara SP; LaRusso NF
Semin Immunopathol; 2022 Jul; 44(4):527-544. PubMed ID: 35178659
[TBL] [Abstract][Full Text] [Related]
3. Biliary innate immunity in the pathogenesis of biliary diseases.
Harada K; Nakanuma Y
Inflamm Allergy Drug Targets; 2010 Jun; 9(2):83-90. PubMed ID: 20402650
[TBL] [Abstract][Full Text] [Related]
4. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
Chung BK; Karlsen TH; Folseraas T
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
[TBL] [Abstract][Full Text] [Related]
5. Bile Acids and Deregulated Cholangiocyte Autophagy in Primary Biliary Cholangitis.
Sasaki M; Nakanuma Y
Dig Dis; 2017; 35(3):210-216. PubMed ID: 28249264
[TBL] [Abstract][Full Text] [Related]
6. Immune-mediated cholangiopathies in children: the need to better understand the pathophysiology for finding the future possible treatment targets.
Grama A; Mititelu A; Sîrbe C; Benţa G; Pop TL
Front Immunol; 2023; 14():1206025. PubMed ID: 37928553
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-mesenchymal transition induced by biliary innate immunity contributes to the sclerosing cholangiopathy of biliary atresia.
Harada K; Sato Y; Ikeda H; Isse K; Ozaki S; Enomae M; Ohama K; Katayanagi K; Kurumaya H; Matsui A; Nakanuma Y
J Pathol; 2009 Apr; 217(5):654-64. PubMed ID: 19116990
[TBL] [Abstract][Full Text] [Related]
8. Stress-induced cellular responses and cell death mechanisms during inflammatory cholangiopathies.
Sasaki M; Nakanuma Y
Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):129-138. PubMed ID: 27618480
[TBL] [Abstract][Full Text] [Related]
9. Biliary innate immunity: function and modulation.
Harada K; Nakanuma Y
Mediators Inflamm; 2010; 2010():. PubMed ID: 20798866
[TBL] [Abstract][Full Text] [Related]
10. Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice.
Guicciardi ME; Krishnan A; Bronk SF; Hirsova P; Griffith TS; Gores GJ
Cell Death Dis; 2017 Jan; 8(1):e2535. PubMed ID: 28055006
[TBL] [Abstract][Full Text] [Related]
11. Functional role of cellular senescence in biliary injury.
Meng L; Quezada M; Levine P; Han Y; McDaniel K; Zhou T; Lin E; Glaser S; Meng F; Francis H; Alpini G
Am J Pathol; 2015 Mar; 185(3):602-9. PubMed ID: 25619959
[TBL] [Abstract][Full Text] [Related]
12. Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis.
Dienes HP; Lohse AW; Gerken G; Schirmacher P; Gallati H; Löhr HF; Meyer zum Büschenfelde KH
Virchows Arch; 1997 Aug; 431(2):119-24. PubMed ID: 9293893
[TBL] [Abstract][Full Text] [Related]
13. Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis.
Cazzagon N; Sarcognato S; Floreani A; Corrà G; De Martin S; Guzzardo V; Russo FP; Guido M
JHEP Rep; 2021 Jun; 3(3):100286. PubMed ID: 34041468
[TBL] [Abstract][Full Text] [Related]
14. Infiltration of inflammatory cells expressing mitochondrial proteins around bile ducts and in biliary epithelial layer may be involved in the pathogenesis in primary biliary cirrhosis.
Sasaki M; Kakuda Y; Miyakoshi M; Sato Y; Nakanuma Y
J Clin Pathol; 2014 Jun; 67(6):470-6. PubMed ID: 24407434
[TBL] [Abstract][Full Text] [Related]
15. Inflammation and biliary tract injury.
Lu BR; Mack CL
Curr Opin Gastroenterol; 2009 May; 25(3):260-4. PubMed ID: 19396964
[TBL] [Abstract][Full Text] [Related]
16. Novel approach to bile duct damage in primary biliary cirrhosis: participation of cellular senescence and autophagy.
Sasaki M; Nakanuma Y
Int J Hepatol; 2012; 2012():452143. PubMed ID: 21994884
[TBL] [Abstract][Full Text] [Related]
17. Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis.
Carpino G; Cardinale V; Renzi A; Hov JR; Berloco PB; Rossi M; Karlsen TH; Alvaro D; Gaudio E
J Hepatol; 2015 Nov; 63(5):1220-8. PubMed ID: 26119688
[TBL] [Abstract][Full Text] [Related]
18. Frequent cellular senescence in small bile ducts in primary biliary cirrhosis: a possible role in bile duct loss.
Sasaki M; Ikeda H; Haga H; Manabe T; Nakanuma Y
J Pathol; 2005 Mar; 205(4):451-9. PubMed ID: 15685690
[TBL] [Abstract][Full Text] [Related]
19. The biliary HCO(3)(-) umbrella: experimental evidence revisited.
Beuers U; Maroni L; Elferink RO
Curr Opin Gastroenterol; 2012 May; 28(3):253-7. PubMed ID: 22450897
[TBL] [Abstract][Full Text] [Related]
20. The immunophysiology and apoptosis of biliary epithelial cells: primary biliary cirrhosis and primary sclerosing cholangitis.
Kawata K; Kobayashi Y; Gershwin ME; Bowlus CL
Clin Rev Allergy Immunol; 2012 Dec; 43(3):230-41. PubMed ID: 22689287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
